Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03059433 · ClinicalTrials.gov registry record
Randomized Trial of a Social Networks Intervention
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 446
- Enrollment target
NCT03059433: Completed study, sponsored by University of California, Los Angeles.
NCT03059433 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 446 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03059433 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 446 participants
- Enrollment target
Study Summary
Advancement via Individual Determination (AVID) is a college preparatory program that provides a unique opportunity to determine whether schools can reduce substance use by re-grouping at-risk students with high-performing students, while providing additional academic and emotional support. Operating in 4,837 K-12th grade schools worldwide and across 45 US states, this widely-disseminated program targets students from groups traditionally underrepresented in higher education who are currently performing in the academic middle (i.e., a 2.0-3.5 grade point average). AVID removes these students from typical classrooms and exposes them to a peer network in which academic performance and positive social norms are valued. In addition, by strengthening the student/teacher relationship, AVID expands students' networks of supportive adults. For low-income minority students in the academic middle, relatively small investments in prevention might significantly impact their academic and health trajectories. AVID capitalizes on a moment when social networks are in flux-the transition to high school-to shift these students' trajectories. This study is a longitudinal, randomized pilot evaluation of AVID among low-income minority adolescents entering high school, comparing academic performance and drug use, as well as other risky behaviors, over 3 years. Although social networks are hypothesized to have a strong influence on behavior, few studies have tried to re-wire networks to change behaviors. This study will provide a clearer understanding of whether schools can intentionally shape networks and whether these changes can reduce substance use. This study will also explore important mechanistic questions about whether and how AVID changes peer networks and relationships with teachers, whether those changes lead to improvements in academic and behavioral outcomes and, if so, what the relative importance of peer versus adult network changes are.
Primary Outcome
Investigators will evaluate whether students randomized to AVID report healthier social networks (lower proportion of peers engaging in risky behaviors and a higher number of supportive adults) than control students.
Interventions
- OTHER AVID Intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 446 participants |
| Start Date | 2017-04-21 |
| Est. Completion | 2022-07-06 |
What the finished NCT03059433 record still lists
NCT03059433 is an observational study that tracks outcomes without assigning an intervention. The registered 446 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which AVID Intervention is the first listed.
NCT03059433 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03059433 about?
NCT03059433 is a clinical study titled "Randomized Trial of a Social Networks Intervention". Advancement via Individual Determination (AVID) is a college preparatory program that provides a unique opportunity to determine whether schools can reduce substance use by re-grouping at-risk students with high-performing students, while providing additional academic and emotional support. Operatin...
What is the current status of trial NCT03059433?
This trial is currently completed. The enrollment target is 446 participants. The study started on 2017-04-21. Estimated completion is 2022-07-06.
What interventions are being tested in trial NCT03059433?
The interventions under investigation include: AVID Intervention (OTHER).
Who is sponsoring clinical trial NCT03059433?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04065399 · 447 participants · Phase 1
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- NCT01280994 · 445 participants · Phase 2
Hyperpolarized 129Xe MRI for Imaging Pulmonary Function
- NCT03504800 · 445 participants
OCT in Diagnosis of Irregular Corneas
- NCT04751435 · 445 participants · NA
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI